LUTONIX
Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. Paclitaxel is an anti-proliferative drug commonly used to prevent arterial restenosis. Lutonix DCB is very similar to a standard angioplasty balloon, but contains a special coating consisting of paclitaxel and a proprietary carrier that facilitates the drug’s transfer to the arterial wall upon inflation. This highly efficient formulation allows Lutonix DCB to deliver a therapeutic dose to the artery wall, while keeping the dose of paclitaxel on the balloon as low as possible. A lower balloon drug load minimizes systemic drug exposure and is designed to maximize safety.
LUTONIX
Industry:
Biotechnology Health Care Medical Device
Founded:
2007-01-01
Address:
Maple Grove, Minnesota, United States
Country:
United States
Website Url:
http://www.lutonix.com
Total Employee:
11+
Status:
Active
Contact:
763-445-2352
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
Microsoft Azure DNS Liquid Web MarkMonitor DNS
Similar Organizations
Kintai Therapeutics
Kintai is a biotechnology company that advancing precision therapeutics based on enteric signaling networks in the human body.
Current Employees Featured
Founder
Investors List
Delphi Ventures
Delphi Ventures investment in Series B - Lutonix
U.S. Venture Partners
U.S. Venture Partners investment in Series B - Lutonix
RiverVest
RiverVest investment in Series B - Lutonix
Versant Ventures
Versant Ventures investment in Series B - Lutonix
Official Site Inspections
http://www.lutonix.com
- Host name: aeedc42b70c898c66.awsglobalaccelerator.com
- IP address: 3.33.139.32
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Lutonix"
Lutonix - Crunchbase Company Profile & Funding
Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. Paclitaxel is an anti-proliferative drug commonly used to prevent arterial restenosis. Lutonix DCB is very similar to a …See details»
Lutonix, Inc. Company Profile | Tempe, AZ - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Lutonix, Inc. of Tempe, AZ. Get the latest business insights from Dun & Bradstreet.See details»
Lutonix Company Profile 2024: Valuation, Investors, Acquisition
Lutonix General Information Description. Developer of drug coated balloon catheters designed to treat vascular disease in the coronary and peripheral arteries. The company's Lutonix drug …See details»
Lutonix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Lutonix, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 9 news, and 1 literature.See details»
Lutonix - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 13, 2010: Series C - …See details»
Lutonix - Products, Competitors, Financials, Employees, …
Lutonix is a medical device company developing drug-coated balloon catheters for the treatment of vascular disease. ... the Veryan Medical BioMimics 3D Vascular Stent System. November 9, …See details»
Lutonix Company Profile -Sales, Contacts, Competitors – Buzzfile
Lutonix is in the Surgical and Medical Instruments industry within the Measuring, Photographic, Medical, & Optical Goods, & Clocks sector and has been in business for approximately 17 …See details»
Lutonix™ Drug Coated Balloon PTA Catheters - BD
Lutonix Global SFA Real-World Registry long lesion cohort was defined as lesions =140mm, and had a freedom from composite safety rate of 76.7% at 24 months. In the LEVANT 2 IDE Clinical Trial, treatment with Lutonix™ 035 DCB …See details»
Lutonix Inc | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Lutonix Company Profile - Office Locations, Competitors ... - Craft
Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. Paclitaxel is an anti-proliferative drug commonly used to prevent arterial …See details»
Lutonix - Overview, News & Similar companies | ZoomInfo.com
Who is Lutonix. Lutonix, Inc., co-Founded in July 2007 by Dennis Wahr, M.D. and Lixiao Wang PhD, is focused on the rapid development and commercialization of the s afest and most …See details»
Lutonix™ Drug Coated Balloon PTA Catheters - BD
The Lutonix Global Registry showed sustained efficacy of Lutonix™ 035 DCB in heterogeneous patient population in real-world clinical practice. 1 The primary efficacy endpoint was …See details»
Lutonix Announces Achievement of Significant Milestones and …
Jun 28, 2011 Lutonix is the first company to receive approval from the FDA to initiate a drug-coated balloon trial. ... we are proud to have them join the organization and know their …See details»
BD drug-coated balloon faces uphill battle in FDA panel review
Feb 16, 2021 An FDA advisory panel will convene on Wednesday to discuss BD's premarket approval application for its Lutonix drug-coated balloon to treat peripheral artery disease below …See details»
Lutonix™ 018 Drug Coated Balloon PTA Catheter | BD Canada
The Lutonix™ 018 DCB utilizes the same proven drug coating formulation as the Lutonix™ 035 DCB, which demonstrated outstanding 24 month freedom from TLR in the following patient …See details»
BD Newsroom - Press releases
Nov 1, 2023 “The Lutonix™ DCB has been used to treat over 400,000 patients worldwide, 2 ” said Tim Hug, Global vice president and general manager of vascular for BD. “The results …See details»
“If we are going to use these devices, we have to use them …
Jun 8, 2023 Comparing their results to the Lutonix global registry trial and the IN.PACT investigational device exemption (IDE) trial, which received 73.9% and 82.2% six month …See details»
Lutonix™ RX Drug Coated Balloon (DCB) - BD
Lutonix™ RX Drug Coated Balloonは、バルーン表面にパクリタキセルを含むコーティング剤を塗布し、バルーンの拡張により血管を機械的に拡張するとともに、薬剤コーティングに含ま …See details»
Lutonix BTK randomised trial meets safety and efficacy endpoints …
Nov 9, 2018 Jihad Mustapha speaking at VIVA 2018. Six-month outcomes of a multicentre randomised controlled trial using the Lutonix 014 drug-coated balloon (BD; DCB) has …See details»